Suppr超能文献

恶性疟原虫烯酰基 ACP 还原酶的动力学及其对药物发现的影响。

Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.

机构信息

Department of Pharmacology, University of California San Diego, La Jolla, California 92093, USA.

出版信息

Protein Sci. 2012 Nov;21(11):1734-45. doi: 10.1002/pro.2155. Epub 2012 Oct 9.

Abstract

Enoyl-acyl carrier protein reductase (ENR) is a crucial enzyme in the type II fatty acid synthesis pathway of many pathogens such as Plasmodium falciparum, the etiological agent of the most severe form of malaria. Because of its essential function of fatty acid double bond reduction and the absence of a human homologue, PfENR is an interesting drug target. Although extensive knowledge of the protein structure has been gathered over the last decade, comparatively little remains known about the dynamics of this crucial enzyme. Here, we perform extensive molecular dynamics simulations of tetrameric PfENR in different states of cofactor and ligand binding, and with a variety of different ligands bound. A pocket-volume analysis is also performed, and virtual screening is used to identify potential druggable hotspots. The implications of the results for future drug-discovery projects are discussed.

摘要

烯酰基辅酶 A 还原酶(ENR)是许多病原体(如疟原虫,即最严重疟疾形式的病原体)中 II 型脂肪酸合成途径的关键酶。由于其脂肪酸双键还原的重要功能以及缺乏人类同源物,PfENR 是一个有趣的药物靶点。尽管在过去十年中已经收集了大量关于该蛋白质结构的知识,但关于这种关键酶的动力学却知之甚少。在这里,我们对不同辅助因子和配体结合状态以及结合了各种不同配体的四聚体 PfENR 进行了广泛的分子动力学模拟。还进行了口袋体积分析,并进行了虚拟筛选以识别潜在的可成药热点。讨论了这些结果对未来药物发现项目的意义。

相似文献

1
Dynamics of Plasmodium falciparum enoyl-ACP reductase and implications on drug discovery.
Protein Sci. 2012 Nov;21(11):1734-45. doi: 10.1002/pro.2155. Epub 2012 Oct 9.
2
High-resolution structures of Thermus thermophilus enoyl-acyl carrier protein reductase in the apo form, in complex with NAD+ and in complex with NAD+ and triclosan.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2012 Oct 1;68(Pt 10):1139-48. doi: 10.1107/S1744309112033982. Epub 2012 Sep 22.
5
Structural basis for triclosan and NAD binding to enoyl-ACP reductase of Plasmodium falciparum.
Biochem Biophys Res Commun. 2001 Apr 27;283(1):224-8. doi: 10.1006/bbrc.2001.4747.
6
Discovery of novel inhibitors targeting enoyl-acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening.
Biochem Biophys Res Commun. 2007 Jul 6;358(3):686-91. doi: 10.1016/j.bbrc.2007.04.113. Epub 2007 Apr 26.
7
Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.
Bioorg Med Chem. 2014 Nov 1;22(21):6053-6061. doi: 10.1016/j.bmc.2014.09.002. Epub 2014 Sep 15.
8
Structural elucidation of the specificity of the antibacterial agent triclosan for malarial enoyl acyl carrier protein reductase.
J Biol Chem. 2002 Apr 12;277(15):13106-14. doi: 10.1074/jbc.M112000200. Epub 2002 Jan 15.
9
Discovery of new potential hits of Plasmodium falciparum enoyl-ACP reductase through ligand- and structure-based drug design approaches.
Bioorg Med Chem Lett. 2013 Apr 15;23(8):2436-41. doi: 10.1016/j.bmcl.2013.02.006. Epub 2013 Feb 13.
10
Studies of Toxoplasma gondii and Plasmodium falciparum enoyl acyl carrier protein reductase and implications for the development of antiparasitic agents.
Acta Crystallogr D Biol Crystallogr. 2007 Mar;63(Pt 3):328-38. doi: 10.1107/S0907444906053625. Epub 2007 Feb 21.

引用本文的文献

1
Exploring Novel Antimalarial Compounds Targeting Enoyl-ACP Reductase: Computational and Experimental Insights.
ACS Omega. 2024 May 13;9(21):22777-22793. doi: 10.1021/acsomega.3c09893. eCollection 2024 May 28.
2
Antimalarial Properties of Isoquinoline Derivative from subsp. Hygroscopicus: An In Silico Approach.
Biomed Res Int. 2020 Jan 9;2020:6135696. doi: 10.1155/2020/6135696. eCollection 2020.
3
Slow-Onset Inhibition of Mycobacterium tuberculosis InhA: Revealing Molecular Determinants of Residence Time by MD Simulations.
PLoS One. 2015 May 21;10(5):e0127009. doi: 10.1371/journal.pone.0127009. eCollection 2015.
4
POVME 2.0: An Enhanced Tool for Determining Pocket Shape and Volume Characteristics.
J Chem Theory Comput. 2014 Nov 11;10(11):5047-5056. doi: 10.1021/ct500381c. Epub 2014 Sep 29.
5
In silico screening for Plasmodium falciparum enoyl-ACP reductase inhibitors.
J Comput Aided Mol Des. 2015 Jan;29(1):79-87. doi: 10.1007/s10822-014-9806-3. Epub 2014 Oct 25.
6
Celastrol inhibits Plasmodium falciparum enoyl-acyl carrier protein reductase.
Bioorg Med Chem. 2014 Nov 1;22(21):6053-6061. doi: 10.1016/j.bmc.2014.09.002. Epub 2014 Sep 15.

本文引用的文献

1
Enoyl acyl carrier protein reductase inhibitors: a patent review (2006 - 2010).
Expert Opin Ther Pat. 2011 Jul;21(7):1007-22. doi: 10.1517/13543776.2011.581227. Epub 2011 Jun 9.
2
Molecular dynamics simulations of protein targets identified in Mycobacterium tuberculosis.
Curr Med Chem. 2011;18(9):1353-66. doi: 10.2174/092986711795029519.
5
POVME: an algorithm for measuring binding-pocket volumes.
J Mol Graph Model. 2011 Feb;29(5):773-6. doi: 10.1016/j.jmgm.2010.10.007. Epub 2010 Nov 3.
6
Structural basis of triclosan resistance.
J Struct Biol. 2011 Apr;174(1):173-9. doi: 10.1016/j.jsb.2010.11.008. Epub 2010 Nov 19.
9
The origin of malignant malaria.
Proc Natl Acad Sci U S A. 2009 Sep 1;106(35):14902-7. doi: 10.1073/pnas.0907740106. Epub 2009 Aug 3.
10
Fragment-based identification of druggable 'hot spots' of proteins using Fourier domain correlation techniques.
Bioinformatics. 2009 Mar 1;25(5):621-7. doi: 10.1093/bioinformatics/btp036. Epub 2009 Jan 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验